Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Urocia is an oral, extended-release food supplement developed by Laboratorios Q Pharma, specifically designed to support urinary health and manage symptoms associated with overactive bladder (OAB), such as urgency, frequency, and nocturia. The formulation typically contains a combination of natural extracts, including pumpkin seed extract (*Cucurbita pepo*) and soy isoflavones (*Glycine max*). It utilizes a specialized sustained-release technology (often referred to as Cronos technology) to ensure a gradual release of active ingredients, providing prolonged support for bladder muscle function and hormonal balance throughout the day and night. It is primarily marketed for women experiencing urinary discomfort, particularly during menopause.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Urocia.